Autophagy and antidepressants

November 11, 2014

FK506 binding protein 51 (FKBP51) regulates acute and chronic effects of treatment with antidepressants via autophagic pathways (processes by which cells break down and recycle their components) in mice and is linked to the clinical response to antidepressants in humans, according to a study published by Theo Rein and colleagues from the Max Planck Institute of Psychiatry, Germany in this week's PLOS Medicine.

The researchers treat wild-type mice and FKBP51 knockout mice (genetically altered animals that make no FKBP51) with antidepressants to show that the stress response and the effect of acute and chronic antidepressants on behavior and on autophagic markers depend on FKBP51. Using cell-based assays, they show that antidepressants and FKBP51 have synergistic effects on the autophagic pathway and that, in human blood cells, FKBP51 levels correlate with the potential of antidepressants to induce autophagic pathways. Finally, the researchers report that the clinical response to antidepressant treatment in 51 patients with depression is associated with levels of FKBP51 and autophagy markers in patient lymphocytes at admission, and with the response of lymphocyte autophagy markers to antidepressant treatment.

The accuracy of these findings is limited by the small number of patients with depression in the analysis, by the use of only male mice in the animal experiments, and by the inability of animal models of depression to fully replicate the human condition.

The authors say: "To our knowledge, these findings provide the first evidence for the molecular mechanism of FKBP51 in priming autophagic pathways; this process is linked to the potency of at least some antidepressants. These newly discovered functions of FKBP51 also provide novel predictive markers for treatment outcome, consistent with physiological and potential clinical relevance."
-end-
Research Article

Funding: The study was financed by the Max Planck Institute of Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Gassen NC, Hartmann J, Zschocke J, Stepan J, Hafner K, et al. (2014) Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans. PLoS Med 11(11): e1001755. doi:10.1371/journal.pmed.1001755

Author Affiliations:

Max Planck Institute of Psychiatry, GERMANY

Contact:

Theo Rein
Max Planck Institute of Psychiatry
+49 (0) 89-30622-531
theorein@mpipsykl.mpg.de

PLOS

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.